Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Ampio Pharmaceuticals, Inc. (AMPE)

-NYSE MKT
5.44 Down 0.08(1.45%) Apr 17, 4:07PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 13   13   13   13  
Cost of Revenue -   -   -   -  
Gross Profit 13   13   13   13  
Operating Expenses
Research Development5,449  4,804  5,249  2,787  
Selling General and Administrative2,101  1,152  1,220  1,312  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,537) (5,943) (6,457) (4,086)
Income from Continuing Operations
Total Other Income/Expenses Net4  (250)(136)(122)
Earnings Before Interest And Taxes(7,533)(6,194)(6,593)(4,208)
Interest Expense -   -   -   -  
Income Before Tax(7,533)(6,194)(6,593)(4,208)
Income Tax Expense -   -   -   -  
Minority Interest193  122  176  30  
Net Income From Continuing Ops(7,340)(6,072)(6,418)(4,179)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,340) (6,072) (6,418) (4,179)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,340) (6,072) (6,418) (4,179)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.